These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
832 related items for PubMed ID: 30500989
1. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling. He B, Peng F, Li W, Jiang Y. J Cell Biochem; 2019 Mar; 120(3):2908-2918. PubMed ID: 30500989 [Abstract] [Full Text] [Related]
2. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G, Chen X, Chen S, Ye W, Hou K, Liang M. J Transl Med; 2016 May 05; 14(1):122. PubMed ID: 27150195 [Abstract] [Full Text] [Related]
3. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p. Deng Y, Wei Z, Huang M, Xu G, Wei W, Peng B, Nong S, Qin H. J Cell Mol Med; 2020 Jan 05; 24(2):1848-1865. PubMed ID: 31880390 [Abstract] [Full Text] [Related]
4. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z. Cell Signal; 2013 May 05; 25(5):1037-43. PubMed ID: 23376496 [Abstract] [Full Text] [Related]
5. LncRNA H19/microRNA-675/PPARα axis regulates liver cell injury and energy metabolism remodelling induced by hepatitis B X protein via Akt/mTOR signalling. Liu Y, Xu L, Lu B, Zhao M, Li L, Sun W, Qiu Z, Zhang B. Mol Immunol; 2019 Dec 05; 116():18-28. PubMed ID: 31574452 [Abstract] [Full Text] [Related]
6. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma. Cui RJ, Fan JL, Lin YC, Pan YJ, Liu C, Wan JH, Wang W, Jiang ZY, Zheng XL, Tang JB, Yu XG. Cancer Med; 2019 Oct 05; 8(14):6358-6369. PubMed ID: 31466138 [Abstract] [Full Text] [Related]
7. LncRNA MALAT1 Promotes Cancer Metastasis in Osteosarcoma via Activation of the PI3K-Akt Signaling Pathway. Chen Y, Huang W, Sun W, Zheng B, Wang C, Luo Z, Wang J, Yan W. Cell Physiol Biochem; 2018 Oct 05; 51(3):1313-1326. PubMed ID: 30481748 [Abstract] [Full Text] [Related]
8. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma. Bai PS, Xia N, Sun H, Kong Y. J Cell Mol Med; 2017 Nov 05; 21(11):3023-3043. PubMed ID: 28557334 [Abstract] [Full Text] [Related]
9. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway. Hou Z, Quan J. Mol Med Rep; 2017 May 05; 15(5):3285-3291. PubMed ID: 28339072 [Abstract] [Full Text] [Related]
10. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma. Song XZ, Ren XN, Xu XJ, Ruan XX, Wang YL, Yao TT. Technol Cancer Res Treat; 2020 May 05; 19():1533033820957023. PubMed ID: 32910747 [Abstract] [Full Text] [Related]
11. HBx drives alpha fetoprotein expression to promote initiation of liver cancer stem cells through activating PI3K/AKT signal pathway. Zhu M, Li W, Lu Y, Dong X, Lin B, Chen Y, Zhang X, Guo J, Li M. Int J Cancer; 2017 Mar 15; 140(6):1346-1355. PubMed ID: 27925189 [Abstract] [Full Text] [Related]
12. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway. Ching RHH, Sze KMF, Lau EYT, Chiu YT, Lee JMF, Ng IOL, Lee TKW. Oncotarget; 2017 Apr 04; 8(14):23507-23516. PubMed ID: 28186991 [Abstract] [Full Text] [Related]
13. 14-3-3ζ binds to hepatitis B virus protein X and maintains its protein stability in hepatocellular carcinoma cells. Tang Y, Zhang Y, Wang C, Sun Z, Li L, Dong J, Zhou W. Cancer Med; 2018 Nov 04; 7(11):5543-5553. PubMed ID: 30358169 [Abstract] [Full Text] [Related]
14. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1. Lu ZP, Xiao ZL, Yang Z, Li J, Feng GX, Chen FQ, Li YH, Feng JY, Gao YE, Ye LH, Zhang XD. Acta Pharmacol Sin; 2015 Oct 04; 36(10):1228-36. PubMed ID: 26073327 [Abstract] [Full Text] [Related]
15. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma. Liu X, Zhang Y, Wang P, Wang H, Su H, Zhou X, Zhang L. Med Sci Monit; 2016 Jul 16; 22():2492-500. PubMed ID: 27421245 [Abstract] [Full Text] [Related]
16. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H. Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554 [Abstract] [Full Text] [Related]
17. Knockdown of long non-coding RNA MALAT1 inhibits growth and motility of human hepatoma cells via modulation of miR-195. Liu D, Zhu Y, Pang J, Weng X, Feng X, Guo Y. J Cell Biochem; 2018 Feb 10; 119(2):1368-1380. PubMed ID: 28722813 [Abstract] [Full Text] [Related]
18. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway. Luo LH, Jin M, Wang LQ, Xu GJ, Lin ZY, Yu DD, Yang SL, Ran RZ, Wu G, Zhang T. J Cell Physiol; 2020 Sep 10; 235(9):6154-6166. PubMed ID: 32020591 [Abstract] [Full Text] [Related]
19. The miR-545/374a cluster encoded in the Ftx lncRNA is overexpressed in HBV-related hepatocellular carcinoma and promotes tumorigenesis and tumor progression. Zhao Q, Li T, Qi J, Liu J, Qin C. PLoS One; 2014 Sep 10; 9(10):e109782. PubMed ID: 25299640 [Abstract] [Full Text] [Related]
20. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. PLoS One; 2011 May 05; 6(5):e19518. PubMed ID: 21573166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]